Uterine Fundus Pressure in Reduction of Cesarean Bleeding
Is Application of Uterine Fundus Pressure With a Sandbag Effective in Reduction of Cesarean Bleeding? A Prospective Case Control Stud
1 other identifier
interventional
482
1 country
1
Brief Summary
Uterine compression methods reduce the amount of postpartum bleeding. In our study, we investigated the effect of fundal pressure, which will be created by a sandbag placed on the abdomen, on reducing post-cesarean bleeding. Material and Methods: A total of 482 patients who delivered by cesarean section (CS) in the Obstetrics Clinic of Fırat University Faculty of Medicine between January 2021 and December 2021 were included in this prospective, randomized, single-center study.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started Jan 2021
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
January 1, 2021
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 31, 2021
CompletedStudy Completion
Last participant's last visit for all outcomes
December 31, 2021
CompletedFirst Submitted
Initial submission to the registry
August 1, 2023
CompletedFirst Posted
Study publicly available on registry
August 23, 2023
CompletedAugust 23, 2023
August 1, 2023
12 months
August 1, 2023
August 21, 2023
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Whether the fundal pressure created by the sandbag placed on the abdomen has an effect on reducing post-cesarean bleeding.
Whether the fundal pressure created by the sandbag placed on the abdomen has an effect on reducing post-cesarean bleeding.
24 hours
Study Arms (1)
Sandbag
OTHERSandbag
Interventions
The standard sandbag used in our clinic, 20 × 20 × 3 cm3 in dimensions and 3 kg in weight
Eligibility Criteria
You may qualify if:
- All cases with CS who had a live pregnancy after 24 weeks of gestation were included in the study.
You may not qualify if:
- Invasion anomaly,
- Diagnosed with preeclampsia,
- Placenta previa cases,
- Hypertensive pregnant women receiving antihypertensive therapy,
- Diabetic pregnant women,
- Multiple pregnancies,
- Major hepatic, cardiac, renal, respiratory disorders
- Deep vein thrombosis during pregnancy,
- Receiving anticoagulant therapy
- Patients who developed atony and uterine rupture in the operating room,
- Suspected placental invasion
- Uterine balloon tamponade
- Arterial embolization
- Uterine and hypogastric artery ligation,
- Uterine compression sutures
- +1 more criteria
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Firat Universitylead
Study Sites (1)
Firat University Faculty of Medicine
Elâzığ, Turkey (Türkiye)
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- STUDY CHAIR
Sehmus Pala
University of Firat
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Masking Details
- The 482 patients who had CS were divided into two groups, control group (n = 246), weighted group (n = 236) was randomized.
- Purpose
- SUPPORTIVE CARE
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Firat University
Study Record Dates
First Submitted
August 1, 2023
First Posted
August 23, 2023
Study Start
January 1, 2021
Primary Completion
December 31, 2021
Study Completion
December 31, 2021
Last Updated
August 23, 2023
Record last verified: 2023-08
Data Sharing
- IPD Sharing
- Will not share